- Cat. No.
- A17165
UK-371804
UK-371804 is a potent urokinase-type plasminogen activator (uPA) inhibitor.
In stock
View Details
-
-
- Cat. No.
- A18680
ZK824859
ZK824859 is an oral available and selective urokinase plasminogen activator (uPA) inhibitor with IC50s of 79 nM, 1580 nM and 1330 nM for human uPA, tPA, and plasmin, respectively.
In stock View Details -
- Cat. No.
- A22379
UK-371804 HCl
Synonyms: UK371804
UK-371804 is a potent and selective urokinase-type plasmogen activator (uPA) inhibitor with excellent enzyme potency (Ki=10 nM) and selectivity profile (4000-fold versus tPA and 2700-fold versus plasmin).
In stock View Details -
- Cat. No.
- A22591
ZK824190
ZK824190 is an orally available and selective urokinase plasminogen activator (uPA) inhibitor as a potential treatment for multiple sclerosis. IC50s of 237, 1600 and 1850 nM for uPA, tPA, and Plasmin, respectively.
In stock View Details -
- Cat. No.
- A76999
Glutaryl-Gly-Arg-AMC
Glutaryl-Gly-Arg-AMC is a specific peptide substrate for urokinase plasminogen activator (uPA). This compound is utilized in biochemical assays to measure uPA activity, making it a valuable tool in research focused on cancer metastasis and tissue remodeling processes. Its fluorescent properties allow for sensitive detection and quantification of uPA activity in various biological samples.
In stock View Details -
- Cat. No.
- A77771
UK-356202
UK-356202 is a potent urokinase-type plasminogen activator (uPA) inhibitor, exhibiting a Ki value of 0.037 μM. This compound plays a significant role in modulating fibrinolysis and cellular processes associated with wound healing. Its primary applications include research focused on the topical treatment of chronic ulcerous wounds, providing insights into therapeutic strategies for enhancing tissue repair and regeneration.
In stock View Details